Search Results

Mature cancer care patient Tremendous advances are made every day in the fight against cancer, but many promising treatments are costly, placing patients under enormous financial pressure. The challenges of increasing premiums, deductibles, and copayments affect many, with up to 61% of cancer patients facing difficulties in their care.1 Patients in Maryland Have a Choice in Cancer…

Elacestrant versus Standard Endocrine Therapy in Women and Men with Node -positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence – A Global, Multicenter, Randomized, Open-label Phase 3 Study (ELEGANT)(STML-ELA-0422) MOA: Elacestrant is an oral SERD and ER antagonist. Key Eligibility Criteria: Women or men with confirmed ER-positive (≥10% by IHC), HER2-negative…

Doctor consulting with a patient. Radiation therapy is one of the most common treatments for cancer—it can be used to target cancer cells, relieve symptoms associated with cancer, or prevent cancer from returning. It may be used alone or in combination with other treatments like surgery, chemotherapy, hormones, or targeted therapy.  Radiation therapy uses strong…

A Phase 2 Study Evaluating The Efficacy And Safety Of TORL-1-23 In Women With Advanced Platinum Resistant Epithelial Ovarian Cancer (Including Primary Peritoneal And Fallopian Tube Cancers) Expressing Claudin 6 (CLND6) (TORL123-002) MOA: TORL-1-23 is an ADC that targets CLDN6 and contains a MMAE payload. Key Eligibility Criteria: Histologically or cytologically confirmed diagnosis of advanced…